港股異動 | 中國人壽漲逾3%領漲恆指 料前三季度淨利同比增長180%-200%
格隆匯10月21日丨中國人壽(2628.HK)今日高開高走,現報19.48港元,漲3.84%暫領漲恆指,暫成交2.9億港元,最新總市值5506億港元。中國人壽上週五(18日)盤後發公告稱,公司今年前三季度歸屬於母公司股東的淨利潤預計同比增加約357.64億元(人民幣,下同)到397.38億元,同比增加約180%到200%。增長的主要原因有投資收益的影響、非經常性損益的影響等。摩通近日發報告指,本年至今內險股股價累升19%,跑贏恆指同期6%升幅,主要受強勁盈利表現所帶動。內險為中國各行業中每股盈利增長最高的行業,亦是唯一獲市場向上調整盈利預測的行業,受惠於有利的季節性因素,料第三季可維持相關趨勢。該行偏好國有險企,列中國人壽及人保為第三季季績期首選,評級“增持”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.